Stem cell treatment for liver cirrhosis
Treatments studied
Part of Digestive system clinical trials.
This study tests a new treatment made from stem cells (from umbilical cord fluid) that may help reduce liver scarring and improve liver function in people with cirrhosis. It is an early-stage trial to see if the treatment is safe and feasible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a confirmed diagnosis of liver cirrhosis (scarring of the liver).
- Your liver disease must be classified as Child-Pugh Class B, meaning moderate severity.
- You must be in a stable condition, without recent severe problems like active bleeding, serious infection, or significant kidney failure.
- You must not have taken any experimental drugs for liver cirrhosis in the last 6 months.
- You must not have any cancer, be pregnant or breastfeeding, or have a history of allergy to the study treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment using stem cells for people with liver cirrhosis caused by alcohol, hepatitis B, or hepatitis C. The goal is to see if it is safe and if it can help improve liver function.
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
This trial is testing a new treatment made from human stem cells to see if it is safe and helpful for people whose seizures are not controlled by current medications. If you have drug-resistant epilepsy, this treatment might offer a new option.
This trial tests umbilical-cord stem cells to see if they can improve outcomes in people with decompensated (worsening) cirrhosis. You may be considered if your liver disease is moderate to severe (MELD 15–30) and you do not have certain high-risk problems right now.
This study tests whether stem cells from umbilical cord blood can safely help people with advanced liver scarring (cirrhosis) caused by hepatitis B. It may offer a new option for those who haven't improved with usual treatments.
This trial tests an injection of stem cells from donated umbilical cords to see if it can help people with advanced liver scarring from hepatitis B. You may be able to join if standard treatments haven’t helped enough and you aren’t able to get a liver transplant.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.